Newsroom

Intera Oncology is proud to announce that the FDA has approved the manufacture of the Intera 3000 Hepatic Artery Infusion (HAI) Pump for HAI therapy for patients with colorectal cancer and cholangiocarcinoma. The Intera 3000HAI Pump is now the only FDA-approved pump for HAI. “We formed Intera Oncology to bring this pump back to market after it was discontinued by another company. We could not let those who stood to benefit from HAI therapy go without that option,” said Michael Gaisford, president and CEO of Intera Oncology. “We are thrilled that we have accomplished our mission and that HAI therapy will be available to those who need it.”

A chemotherapy infusion pump is giving more time to people whose metastatic colorectal cancer has spread to the liver and who may have been told they are out of options. Duke Health surgical oncologists were the first to implant the Hepatic Artery Infusion (HAI) pump after it received FDA approval. Duke Health

Michael Gaisford has been named CEO of Intera Oncology, a medical device company dedicated to ensure Hepatic Artery Infusion therapy is available to any patient who could benefit from it. Gaisford brings 15 years’ experience leading strategy, marketing, and product management teams. Prior to Intera, Gaisford was Director of Marketing for Stratasys Healthcare Solutions where he oversaw global marketing programs across medical and dental markets. At Boston Scientific, he held positions in corporate strategy, marketing and divisional product marketing. Gaisford previously worked at Genentech, CVS/Pharmacy, and McKinsey & Company. He holds an MBA from the Tuck School of Business at Dartmouth and BS from Stanford University.

Two doctors determined to resurrect a medical pump that increases survival of some patients with colorectal cancer and cholangiocarcinoma have launched Intera Oncology. Drs. Jonathan Reis and David Dove both have loved ones who benefitted from the only FDA-approved pump that delivers chemotherapy directly to the liver via “Hepatic Artery Infusion therapy” (HAI). When they found that the pump was to be discontinued, the doctors formed Intera Oncology to once again make the pump available to those who may benefit from it.

A medical device that can add years to the lives of cancer patients is about to become unavailable, because its manufacturer has decided to stop producing it. New York Times